Customers in Japan Can Now Purchase the Daisy Petal ® Perfusion Bioreactor System
MEDFORD, Mass. – Sunflower Therapeutics (Sunflower®), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today that it has engaged MATSUBO Corporation as its exclusive distributor for the Daisy Petal® Perfusion Bioreactor System in Japan. This marks Sunflower’s second commercial partnership within the Asian region, representing a key step in its international growth strategy.
“MATSUBO is a premier partner known for serving as a bridge for advanced technology in the region,” said Dr. Kerry Love, CEO and co-founder of Sunflower Therapeutics. “Their approach goes beyond simple distribution; they provide total support—from initial consulting to installation and localization. We are confident that MATSUBO’s engineering expertise and deep regional roots will ensure our Japanese customers have the technical backing they need to adopt continuous manufacturing with confidence.
Sunflower’s innovative Daisy Petal® is a breakthrough technology designed for high-efficiency protein production using an intuitive, single-use assembly. The system features a disposable stirred tank reactor with an integrated in-vessel cell retention device that enables continuous biomass feeding, fluid harvesting, and perfusion, which results in significantly higher space-time yields compared to traditional fed-batch fermentation.
“Partnering with Sunflower Therapeutics allows MATSUBO to bring a cutting-edge protein fermentation solution to the expanding Japanese biologics market,” said Makoto Tsukiyama, President and CEO of MATSUBO Corporation. “Our customers in the protein manufacturing sectors require equipment that drives innovation while maintaining reliability. The Daisy Petal stands out by offering advanced automation in a scalable format, and we look forward to supporting its deployment across the country.”
The Daisy Petal® System is supported by Sunflower’s GMP-compliant bioprocessing software suite, which includes HelianthOS™, Nursery™, and Harvest™. These tools provide a cohesive ecosystem for walkaway automation, allowing for the easy development of process recipes without coding and the secure storage of process data.
To learn more about the Daisy Petal®, visit https://sunflowertx.com/
About Sunflower Therapeutics
Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods and Contract Research Organization (CRO) services for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.
About MATSUBO Corporation
MATSUBO Corporation contributes to the industrial world by serving as a bridge for technology through the introduction of advanced technology from throughout the world. We introduce the latest Japanese and overseas equipment, machinery, and technology for food, chemicals, pharmaceuticals, steel and non-ferrous metals, paper, and electronics to our customers. MATSUBO’s business is not only to act as an import agent for machinery and equipment, but to provide total support including consulting prior to introduction, engineering services for installation and localization, and provide maintenance and propose improvements and modifications after introduction. We stand in the customer’s shoes and get involved with developing technology and manufacturing products. We are also involved in activities for joint development of new technology with manufacturers and research institutions. For further information please visit https://www.matsubo.co.jp/en/
Contacts
Media:
Sunflower Therapeutics
Dave Bianchi, Director of Commercial Operations
info@sunflowertx.com